The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.60
Bid: 91.60
Ask: 92.80
Change: -0.80 (-0.86%)
Spread: 1.20 (1.31%)
Open: 94.40
High: 94.40
Low: 92.00
Prev. Close: 93.40
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

De La Rue secures multiple tax stamp contracts

28 Mar 2019 09:00

RNS Number : 2354U
De La Rue PLC
28 March 2019
 

DE LA RUE PLC

De La Rue secures multiple tax stamp contracts

 

28 March 2019

De La Rue, the world's leading security and anti-counterfeiting solution provider, has today announced it has secured multiple contracts to supply tobacco tax stamps which will be used to fight illicit trade and to reduce risks to citizens' health in six European countries.

The contracts will see De La Rue deliver more than 3.5 billion tax stamps each year to be applied on tobacco products sold in the UK, France, Austria, Sweden, Finland and Cyprus. The awards will more than triple its annual volume of authentication labels in FY2019/20.

The tax stamps are custom designed to meet the specific requirements of each of these countries. In compliance with the EU Tobacco Products Directive (EUTPD), the stamps also contain visible and invisible security features which are required to enable authorities and consumers to verify the authenticity of the tobacco products.

As part of its strategy to grow the Product Authentication & Traceability (PA&T) business, De La Rue has been investing heavily to boost its capabilities, product and service offerings in this area. These include installing a £10m new production line in Malta in 2018 to increase capacity and flexibility for tax stamps and secure labels. De La Rue also invests continuously to enhance DLR Certify™, the software platform that underpins its track and trace solution.

In support of the implementation of the EUTPD in the UK, De La Rue was appointed in February 2019 by HMRC to implement a digital track and trace system for all tobacco products sold in the UK and to manage the service for HMRC with the estimated 57,000 economic operators serving the UK tobacco sector.

Martin Sutherland, Chief Executive Officer of De La Rue, commented:

"We are pleased to have made further progress in growing our PA&T business. The tax stamp market is large and fast growing and as one of the largest tax stamp solution providers, we believe we are best placed to capture this opportunity."

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

 

Enquiries:

 

De La Rue plc +44 (0)1256 605000

Sinead Keller Head of Media

Lili Huang Head of Investor Relations

 

Brunswick +44 (0)207 404 5959

Azadeh Varzi

Stuart Donnelly

 

 

Notes to editors

1) De La Rue's PA&T segment comprises two business activities: government revenue services or tax stamp solutions, and brand protection solutions for businesses. De La Rue delivered 1.6 billion authentication labels in FY17/18.

2) Counterfeit and contraband cigarettes account for one in ten cigarettes being consumed in the EU, and the illicit tobacco trade is costing EU governments €10bn in tax revenue annually (source: KPMG report).

3) EU Tobacco Products Directive is a directive of the European Union that aims to improve the functioning of the internal market for tobacco and related products, while ensuring a high level of health protection for EU citizens. Articles 15 and 16 of the Directive specify the purposes and requirements for the systems of traceability and security features for tobacco products to address the issue of illicit trade.

 

About De La Rue

De La Rue's purpose is to enable every citizen to participate securely in the global economy. As a trusted partner of governments, central banks and commercial organisations, De La Rue provides products and services that underpin the integrity of trade, personal identity and the movement of goods.

As the world's largest designer and commercial printer of banknotes, De La Rue designs, manufactures and delivers banknotes, banknote substrates and security features to customers in a world where currency will continue to be a key part of the developing payments eco-system. De La Rue is the only integrated supplier of both paper and polymer banknotes, and creates security features that ensure banknotes are protected against counterfeiting.

De La Rue is the world's largest commercial designer and printer of passports, delivering national and international identity tokens and software solutions for governments in a world that is increasingly focused on the importance of a legal and secure identity for every individual.

De La Rue also creates and delivers secure product identifiers and 'track and trace' software for governments and commercial customers alike to help to tackle the challenge of illicit or counterfeit goods and the collection of revenue and excise duties.

De La Rue is listed on the London Stock Exchange (LSE:DLAR). For further information visit www.delarue.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAXDXAELNEFF
Date   Source Headline
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.